Frameworks for Digital Advertising
Standards in Medicine.

United Kingdom · Advertising framework

Print advertising and advertorials for diagnostic tests and services in the United Kingdom

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Check medical classification and claim evidence

Regulator guidance

Medical claims and cosmetic claims need an appropriate evidential and regulatory basis. A conformity marking does not establish every claimed benefit. Check the current MHRA device regime for GB or Northern Ireland separately; this baseline does not specify transition deadlines or decide a software classification.

Sources: CAP Code section 12: medicines, devices, health and beauty

Keep GB device transitions separate from Northern Ireland

Regulator guidance

For GB, the cited MHRA guidance accepts valid MDD/AIMDD CE devices until certificate expiry or 30 June 2028, whichever is earlier; IVDD devices until expiry or 30 June 2030; and EU MDR/IVDR devices until 30 June 2030. Check eligibility and certificate validity rather than applying one date to all devices.

Northern Ireland follows EU MDR/IVDR. UKCA alone is insufficient there; use the applicable CE route, including CE plus UK(NI) where a UK body is used. These market-access rules do not substantiate advertising claims.

Sources: Regulating medical devices in the UK; Medical-device regulation in Northern Ireland

Channel rules

Check the complete consumer-facing message

Regulator guidance

The DMCC consumer-protection regime addresses misleading claims, deceptive overall presentation and material omissions. Support factual statements with evidence and present important conditions in time for an informed decision. Review prices, qualifications and commercial intent alongside the health-sector requirements.

Sources: Unfair commercial practices: CMA207

Review at final printed size

Editorial recommendation

Approve the advertorial label, full layout and legibility at actual size. Check what must appear in the advertisement itself before moving details behind a QR code.

Campaign workflow

Diagnostics & Health Testing: prepare the review

Editorial recommendation

Separate a test kit, laboratory service, screening package and medical interpretation. State the intended population and explain the limits of a positive or negative result. Review both product rules and provider rules when a device is bundled with a clinical service.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Separate a test kit, laboratory service, screening package and medical interpretation.
  • State the intended population and explain the limits of a positive or negative result.
  • Review both product rules and provider rules when a device is bundled with a clinical service.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • Windsor medicine licensing and the GB/NI device distinction are now documented. Verify the exact authorisation, certificate validity, transitional eligibility and destination market. Food-claim transitions, other professional regulators and broadcaster-specific clearance remain separate checks.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

Advertising diagnostic tests and services in print campaigns in the United Kingdom requires a distinction between the test product, the laboratory service and the interpretation of the result. Use this framework to review those layers and the limits of the advertised outcome.

Printed advertisements must work at their final physical size. Review the advertorial label, required information, images and multipage layout together, including what stays on the page when a QR code points readers elsewhere.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. UK advertising baseline with a required Great Britain versus Northern Ireland product-regime check. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. CAP Code section 12: medicines, devices, health and beauty

    Committee of Advertising Practice / ASA · self regulatory code · checked 2026-10-24

    Use the operative rules; the page’s historical device-transition dates are not used as current market-access guidance. Broadcast advertisements require BCAP review.

  2. Unfair commercial practices: CMA207

    Competition and Markets Authority · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  3. Regulating medical devices in the UK

    MHRA · regulator guidance · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  4. Medical-device regulation in Northern Ireland

    MHRA · regulator guidance · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

From framework to action

Local expertise in United Kingdom

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in United Kingdom.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in United Kingdom

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.